Share-based Compensation (Details) (USD $)	3 Months Ended			3 Months Ended		12 Months Ended	0 Months Ended	3 Months Ended			12 Months Ended	0 Months Ended			3 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Mar. 31, 2013	Jun. 30, 2013 Stock Options [Member]	Jun. 30, 2012 Stock Options [Member]	Mar. 31, 2013 Stock Options [Member]	Jul. 23, 2013 Stock Options [Member] New Chief Executive [Member]	Jun. 30, 2013 Stock Options [Member] Maximum [Member]	Jun. 30, 2012 Stock Options [Member] Consultants [Member]	Jun. 30, 2013 Restricted Stock [Member]	Mar. 31, 2013 Restricted Stock [Member]	Jul. 23, 2013 Stock Compensation Plan [Member] New Chief Executive [Member]	Jul. 23, 2013 2006 Amended Stock and Incentive Plan [Member]	Jun. 30, 2013 2006 Amended Stock and Incentive Plan [Member] Plan	Jun. 30, 2013 2006 Amended Stock and Incentive Plan [Member] Stock Options [Member] Minimum [Member]	Jun. 30, 2013 2006 Amended Stock and Incentive Plan [Member] Stock Options [Member] Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of active plans for share-based compensation grants														1
Number of shares reserved for share-based grants (in shares)														2,700,000
Stock grants	20,934,245		21,005,582									300,000
Shares available for grant (in shares)													295,000	1,275,000
Term of share-based payment award (in years)															5 years	7 years
Vesting period																3 years
Share-based compensation and consulting expense	$ 16,000	$ 164,000							$ 2,000
Weighted-average assumptions used to value the options granted [Abstract]
Expected life in years				5 years 6 months 11 days	4 years 8 months 26 days
Risk free interest rate (in hundredths)				0.84%	0.82%
Expected volatility (in hundredths)				81.96%	91.44%
Expected dividend yield (in hundredths)				0.00%	0.00%
Weighted-average grant date fair value (in dollars per share)				$ 1.42	$ 2.24
Forfeiture rate (in hundredths)								18.00%
Stock options, number of shares [Roll Forward]
Outstanding, beginning of period (in shares)				2,016,000
Options granted (in shares)				12,000			700,000
Non-cash charges							74,000					700,000
Options surrendered (in shares)				(205,000)
Outstanding, end of period (in shares)				1,823,000		2,016,000
Exercisable, end of period (in shares)				1,584,000
Stock options, weighted average exercise price [Roll Forward]
Outstanding, beginning of period (in dollars per share)				$ 3.51
Options granted (in dollars per share)				$ 2.11
Options surrendered (in dollars per share)				$ 3.64
Outstanding, end of period (in dollars per share)				$ 3.48		$ 3.51
Exercisable, end of period (in dollars per share)				$ 3.45
Stock options, additional disclosures [Abstract]
Outstanding, aggregate intrinsic value, end of period				444,000		598,000
Exercisable, aggregate intrinsic value, end of period				444,000
Outstanding, weighted average remaining life in years				2 years 6 months 11 days		2 years 7 months 20 days
Exercisable, Weighted average remaining life in years				2 years
Fair value of stock options vested				180,000	249,000
Forfeiture risk, expiration period	4 years
Restricted shares, number of shares [Roll Forward]
Balance, beginning of period (in shares)										180,000
Shares vested (in shares)										(29,000)
Shares forfeited (in shares)										(71,000)
Balance, end of period (in shares)										80,000	180,000
Restricted shares, weighted average grant date fair value [Roll Forward]
Balance, beginning of period (in dollars per share)										$ 4.39
Shares vested (in dollars per share)										$ 4.71
Shares forfeited (in dollars per share)										$ 4.42
Balance, end of period (in dollars per share)										$ 4.24	$ 4.39
Restricted shares, additional disclosures [Abstract]
Weighted average remaining life in years										1 year 9 months 4 days	1 year 6 months
Outstanding, Aggregate intrinsic value										337,000	790,000
Unrecognized share-based compensation expense	$ 713,000
Unrecognized compensation expense, weighted average period of recognition	2 years